National expert to speak on mental illness science and policy April 23-24

Albuquerque, Santa Fe events free and open to public

Renowned speaker Alan I. Leshner, PhD, will present an engaging look at history and the interplay of science and policy relating to mental illness in Santa Fe Thursday, April 23, 6 p.m., in the Harold L. Runnels Building Auditorium, 1190 S. St. Francis Dr.; and in Albuquerque Friday, April 24, 6 p.m., in Domenici Center Auditorium on UNM’s North Campus, 1001 Stanford NE. Admission to both is free but reservations are recommended.

Lesher, honored speaker during the UNM Department of Psychiatry and Behavioral Sciences 50th anniversary celebration, will present, Evolving Ideas about Mental Disorders and Why They Matter. He is CEO Emeritus of the American Association for the Advancement of Science and has served in leadership roles as director of the National Institute of Mental Health and deputy director of the National Institute on Drug Abuse.

Leshner has spent much of his career writing and speaking about the intersection of science and culture. He has published extensively for both the scientific and lay communities on the biology of behavior, science and technology policy, science education and public engagement with science. In recognition of his broad knowledge and numerous contributions, Leshner was appointed to the National Science Board by President Bush in 2004 and reappointed by President Obama in 2011.

To register, visit Public Talks at http://psychiatry.unm.edu/ or call 505/272-3592.

Categories: School of Medicine, Community

Related Stories

Getting Real

Getting Real

UNM's Health Sciences Library and Informatics Center creates immersive learning experience
UNM BATCAVE Joining Forces with Argentina

UNM BATCAVE Joining Forces with Argentina

Lights flashed and the steady beep of a vital signs monitor filled the room as a group of scrub-wearing Argentine health professionals surrounded a patient in an OR setting.
Visionary Research

Visionary Research

UNM team joins multi-site study of genetic risks for diabetes-related blindness